| Literature DB >> 34179095 |
Edoardo Milanetti1,2, Mattia Miotto1,2, Lorenzo Di Rienzo2, Madhu Nagaraj3, Michele Monti4,5, Thaddeus W Golbek6, Giorgio Gosti2, Steven J Roeters6, Tobias Weidner6, Daniel E Otzen3, Giancarlo Ruocco1,2.
Abstract
We propose a computational investigation on the interaction mechanisms between SARS-CoV-2 spike protein and possible human cell receptors. In particular, we make use of our newly developed numerical method able to determine efficiently and effectively the relationship of complementarity between portions of protein surfaces. This innovative and general procedure, based on the representation of the molecular isoelectronic density surface in terms of 2D Zernike polynomials, allows the rapid and quantitative assessment of the geometrical shape complementarity between interacting proteins, which was unfeasible with previous methods. Our results indicate that SARS-CoV-2 uses a dual strategy: in addition to the known interaction with angiotensin-converting enzyme 2, the viral spike protein can also interact with sialic-acid receptors of the cells in the upper airways.Entities:
Keywords: SARS-CoV-2; shape complementarity; sialic acid; spike (S) protein; zernike moments
Year: 2021 PMID: 34179095 PMCID: PMC8219949 DOI: 10.3389/fmolb.2021.690655
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Computational protocol for the characterization of each surface region and the blind identification of the binding sites. (A) Molecular solvent-accessible surface of a protein (in blue) and example of patch selection (red sphere). (B) The selected patch points are fitted with a plane and reoriented in such a way that the z-axis (dotted line) passes through the centroid of the points and is orthogonal to the plane. A point C along the z-axis is defined, such as that the largest angle between the perpendicular axis and the secant connecting C to a surface point is equal to 45°. Finally, to each point, its distance, r with point C is evaluated. (C) Each point of the surface is projected on the fit plane, which is binned with a square grid. To each pixel, the average of the r values of the points inside the pixel is associated. (D) The resulting 2D projection of the patch can be represented by a set of 2D Zernike invariant descriptors. (E–F) Given a protein-protein complex (PDB code: 3B0F, in this example), for each surface vertex we select a patch centered on it and compute its Zernike descriptors. To blindly identify the binding sites, each sampled patch is compared with all the patches of the molecular partner, after which the minimum distance between its patch and all the patches of the molecular partner is associated with each vertex. (G) The surface point values are smoothed to highlight the signal in the regions characterized mostly by low distance values, (i.e. high shape complementarity).
FIGURE 2Comparison between the binding regions of the SARS-CoV and SARS-CoV-2 spike protein with human ACE2. (A1,2) Patch projections in the unitary circle (see Section 4) for the two ACE2 binding regions of the SARS-CoV spike protein. (A3,4) Patch projections in the unitary circle for the SARS-CoV spike binding regions of the human ACE2 receptor. (A5) Distance distribution between the two SARS-CoV spike binding sites on ACE2 and randomly selected patches on the spike protein of SARS-CoV. Decoy patches are sampled taking two random regions separated by the same distance measured between the centers of the spike-ACE2 binding site identified in the experimental structure. The red dotted line represents the distance between the real ACE2 and spike patches, calculated from the experimental structure of the complex. (B) The same as (A) but for the binding site of SARS-CoV-2 and the human ACE2 receptor. The real distances are in the first and fifth percentiles of the distributions for SARS-CoV and SARS-CoV-2, respectively.
FIGURE 3Identification of a SARS-CoV-2 spike region very similar to the sialic-acid binding site on MERS-CoV spike. (A) From left to right, projected region of the real sialic-acid binding site on MERS-CoV, electrostatic potential surface of the same region and cartoon representation of the MERS-CoV spike protein with the binding site highlighted. (B) Putative sialic-acid binding region on SARS-CoV-2 as predicted by our Zernike-based method. From left to right, the projected region of putative interaction site between SARS-CoV and sialic acid, electrostatic potential surface, and cartoon representation of the SARS-CoV spike protein with the binding site highlighted. (C) Same as (B) but for SARS-CoV spike protein.
FIGURE 4Sequence and structure comparison of the N-terminal region of MERS-CoV, SARS-CoV-2 and SARS-CoV. (A) A multiple sequence alignment between the MERS-CoV, the SARS-CoV and the SARS-CoV-2 spike protein sequence. (B) Structural comparison between MERS-CoV and SARS-CoV-2 A-domain. The three segments of the sialic-acid binding site for MERS-CoV spike and the proposed binding site on SARS-CoV-2 spike are highlighted. (C) Structural comparison between SARS-CoV and SARS-CoV-2 A-domain. The proposed binding site on SARS-CoV-2 has no corresponding structure in the SARS-CoV spike.